Deciphera Pharmaceuticals (DCPH) Misses Q1 EPS by 1c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q1 EPS of ($0.60), $0.01 worse than the analyst estimate of ($0.59). Revenue for the quarter came in at $33.4 million versus the consensus estimate of $35.69 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c